NCT05101382 A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
| NCT ID | NCT05101382 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IFOM ETS - The AIRC Institute of Molecular Oncology |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-10-28 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-10-28 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing multi-institutional research program).
Eligibility Criteria
Inclusion Criteria: * Histologically-confirmed diagnosis of colorectal cancer (any stage). * Age \>18 years at the time of diagnosis. * Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides. * Verification that the patient could not be reached for informed consent in accordance with applicable national regulations. Exclusion Criteria: * if inclusion criteria are not met
Contact & Investigator
Silvia Marsoni, MD
STUDY DIRECTOR
IFOM ETS - The AIRC Institute of Molecular Oncology
Frequently Asked Questions
Who can join the NCT05101382 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05101382 currently recruiting?
Yes, NCT05101382 is actively recruiting participants. Contact the research team at clinical.trials@ifom.eu for enrollment information.
Where is the NCT05101382 trial being conducted?
This trial is being conducted at Genova, Italy, Milan, Italy, Milan, Italy, Milan, Italy and 9 additional locations.
Who is sponsoring the NCT05101382 clinical trial?
NCT05101382 is sponsored by IFOM ETS - The AIRC Institute of Molecular Oncology. The principal investigator is Silvia Marsoni, MD at IFOM ETS - The AIRC Institute of Molecular Oncology. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.